Midcap Pharma Company Marksans Pharma Reaches All-Time High, Supported by MarketsMOJO 'Buy' Call
Marksans Pharma, a midcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high on November 30th, 2024. This is supported by a 'Buy' call from MarketsMojo and the stock is currently trading above its moving averages. With a gain of 2.31% in the sector and a 1-year increase of 114.82%, Marksans Pharma has proven to be a strong player in the industry.
Marksans Pharma, a midcap pharmaceutical company, has recently seen a surge in its stock price, reaching an all-time high on November 30th, 2024. This positive trend has been supported by a 'Buy' call from MarketsMOJO, a leading financial advisory firm.
The stock has been performing well, with today's price hitting a new 52-week high of Rs.354.15. Despite underperforming the sector by -0.29%, Marksans Pharma has shown a strong intraday high of Rs.354.15, a 5.45% increase. This is further reinforced by the fact that the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In the pharmaceuticals and drugs sector, Marksans Pharma has shown a gain of 2.31%, indicating a positive sentiment towards the company. This is also reflected in the company's 1-year performance, which has seen a significant increase of 114.82%, compared to the Sensex's performance of 19.28%.
Marksans Pharma's success can be attributed to its strong presence in the midcap market and its consistent performance in the pharmaceutical industry. With a focus on quality and innovation, the company has been able to attract investors and gain a positive reputation in the market.
As a midcap company, Marksans Pharma has shown great potential for growth and has proven to be a strong player in the pharmaceutical industry. With its recent surge in stock price and positive outlook, it is definitely a company to watch out for in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
